论文部分内容阅读
目的观察妥布霉素地塞米松滴眼液预防白内障超声乳化晶体摘除术+人工晶体植入术切口感染的临床疗效。方法选取永州职业技术学院附属医院眼科2012年7—12月行白内障超声乳化晶体摘除术+人工晶体植入术患者157例(眼),按入院日期单双日将患者分为试验组76例与对照组81例。试验组术前及术后使用妥布霉素地塞米松滴眼液滴术眼,对照组术前及术后使用妥布霉素地塞米松滴眼液滴术眼,并于术前0.5 h静脉滴注头孢唑林。观察两组患者术后感染情况。结果两组患者术后均未出现疼痛、眼压升高、视力急降、光感消失、脓性分泌物等不良症状。结论妥布霉素地塞米松滴眼液预防白内障摘除术和人工晶体植入术切口感染的临床疗效确切,无需预防性静脉滴注头孢唑林。
Objective To observe the clinical efficacy of tobramycin dexamethasone eye drops in preventing phacoemulsification cataract extraction and intraocular lens implantation incision infection. Methods 157 cases (eyes) undergoing cataract extraction with phacoemulsification and intraocular lens implantation from July 2012 to July 2012 in our hospital were divided into two groups according to hospitalization date: single and double day. The patients were divided into experimental group (76 cases) The control group of 81 cases. The experimental group was treated with tobramycin dexamethasone eye drops before and after operation, and the control group was treated with tobramycin dexamethasone eye drops before and after operation, and 0.5 h Intravenous cefazolin. Postoperative infection was observed in both groups. Results There was no postoperative pain, elevated intraocular pressure, decreased sharpness of eyesight, loss of sensation of light, purulent discharge and other adverse symptoms in both groups. Conclusion The clinical efficacy of tobramycin dexamethasone eye drops in preventing cataract extraction and intraocular lens implantation incision infection is exact without the need of prophylactic intravenous injection of cefazolin.